Arteriosclerosis, Barker's hypothesis, homocysteine and bandworm
Gräsbeck, R.
Duodecim; Laaketieteellinen Aikakauskirja 120(15): 1911-1912; Discussion 1912
2004
ISSN/ISBN: 0012-7183 PMID: 15508767 Document Number: 579433
Document emailed within 1 workday
Related Documents
Klebanoff, M.A.; Secher, N.J.; Mednick, B.R.; Schulsinger, C. 1999: Maternal size at birth and the development of hypertension during pregnancy: a test of the Barker hypothesis Archives of Internal Medicine 159(14): 1607-1612Van der Linden, J.; van der Linden, W.; Taube, A. 2007: Berkson's fallacy: aortic arteriosclerosis and stroke as an example. Contradictory findings support the hypothesis of low risk of calcium plaque Lakartidningen 104(1-2): 35-37
Lyne 1998: Maurice anthony barker Bmj 316(7142): 1464
Nurk, E.; Tell, G.S.; Vollset, S.Emil.; Nygård, O.; Refsum, H.; Ueland, P.M. 2002: Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study Archives of Internal Medicine 162(12): 1374-1381
Ducros, V.; Candito, M.; Caussé, E.; Couderc, R.; Demuth, K.; Diop, M.E.; Drai, J.; Gachon, A.M.; Garcia, I.; Gerhardt, M.F.; Philippe-Bourgeois, C.; Read, M.H.; Sauvant, M.P. 2001: Plasma homocysteine measurement: a study of pre-analytical variation factors for conditions for total plasma homocysteine concentration Annales de Biologie Clinique 59(1): 33-39
Pritchard, M.A.; Kola, I. 1999: The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in down syndrome Journal of Neural Transmission. Supplementum 57: 293-303
Kruś, S.; Pykało, R.; Wawrzonek, L.; Rutkowska, R.; Skrzypek, E. 1985: Coronary arteriosclerosis and alcoholism in a pathomorphological picture: 1. The control group--coronary arteriosclerosis and the incidence of myocardial infarction in non-alcoholics (autopsy data 1978-1983) Polski Tygodnik Lekarski 40(38): 1066-1070
Kruś, S.; Pykało, R.; Wawrzonek, L.; Rutkowska, R.; Skrzypek, E. 1985: Coronary arteriosclerosis in a pathomorphological picture: 3. Comparison of the incidence and intensity of coronary arteriosclerosis and the incidence of myocardial infarction in men, both non-alcoholics and alcoholics Polski Tygodnik Lekarski 40(38): 1075-1078
Kagan-Ponomarev, M.I. 2004: Homocysteine: why is it harmful? Angiologiia i Sosudistaia Khirurgiia 10(1): 45-50
Nilsson, S. 2005: Homocysteine, health and age Lakartidningen 102(36): 2505
Norberg, B. 2006: Homocysteine:crisis--development Lakartidningen 103(5): 305
Cattaneo, M. 1999: Homocysteine and cardiovascular diseases Circulation 100(25): E151
Ducloux, D.; Gérard Motte and Jean-Marc Chalopin 2000: Homocysteine in Renal Disease Clinical Laboratory 46(3-4): 141-151
2003: Lowering plasma homocysteine Medical Letter on Drugs and Therapeutics 45(1168): 85-86
Datta, S.; Pal, S.K.; Mazumdar, H.; Bhandari, B.; Bhattacherjee, S.; Pandit, S. 2009: Homocysteine and cerebrovascular accidents Journal of the Indian Medical Association 107(6): 345-346
Lutteri, L.; Chapelle, J.P.; Gielen, J. 1999: Homocysteine and cardiovascular risk Revue Medicale de Liege 54(6): 541-547
Cheng, T.O. 1999: Homocysteine, B vitamins, and atherosclerosis Circulation 99(3): 459-460
Derbeneva, S.A.; Pogozheva, A.V. 2003: Homocysteine as a coronary risk factor Voprosy Pitaniia 62(5): 43-48
Jacobsen, D.W. 1998: Homocysteine and vitamins in cardiovascular disease Clinical Chemistry 44(8 Pt 2): 1833-1843
Mikeladze, D.; Zhuravliova, E.; Barbakadze, T. 2008: Ras proteins, nitrosylation and homocysteine metabolism Georgian Medical News 162: 30-33